Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI | P10646 | 7/20 | 0.57 |
| ▸ | KDM1A | O60341 | 3/20 | 0.56 |
| ▸ | GLP1R | P43220 | 1/20 | 0.55 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.55 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.55 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.55 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.55 |
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 0.55 |
| ▸ | NMUR1 | Q9HB89 | 1/20 | 0.55 |
| ▸ | MAOB | P27338 | 1/20 | 0.54 |
| ▸ | KDM5A | P29375 | 1/20 | 0.54 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30842159 | 0.93 | NMUR2 (0.64) | TFPIOPRM1OPRD1EPHA2NMUR2 | |
| SCHEMBL30842169 | 0.90 | NMUR2 (0.65) | TFPIOPRM1OPRD1NMUR2NMUR1 | |
| SCHEMBL30176214 | 0.89 | KDM1A (0.60) | TFPIKDM1ANMUR2NMUR1MAOB | |
| SCHEMBL29477190 | 0.87 | TFPI (0.61) | TFPIKDM1AOPRM1OPRK1NMUR2 | |
| SCHEMBL31415954 | 0.87 | KDM1A (0.56) | KDM1AOPRM1OPRK1MAOBKDM5A | |
| SCHEMBL16976076 | 0.87 | KDM1A (0.62) | TFPIKDM1AOPRM1OPRK1EPHA2 | |
| SCHEMBL30842156 | 0.87 | NMUR2 (0.65) | TFPIOPRM1OPRD1NMUR2NMUR1 | |
| SCHEMBL30842174 | 0.86 | MC4R (0.58) | TFPIOPRM1OPRD1EPHA2NMUR2 | |
| SCHEMBL30842181 | 0.86 | NMUR2 (0.64) | TFPIOPRM1OPRD1EPHA2NMUR2 | |
| SCHEMBL30359272 | 0.86 | OPRM1 (0.62) | TFPIKDM1AOPRM1OPRK1NMUR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12552848-B2 | Hydrochloride salts of C5a receptor agonist peptides | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) | 2026-02-17 | — | — | US | claimed |
| US-20240238414-A1 | ANTI-PARASITIC IMMUNOLOGICAL COMPOSITIONS | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 2024-07-18 | — | — | US | claimed |
| US-12552848-B2 | Hydrochloride salts of C5a receptor agonist peptides | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) | 2026-02-17 | — | — | US | disclosed |
| US-20240238414-A1 | ANTI-PARASITIC IMMUNOLOGICAL COMPOSITIONS | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 2024-07-18 | — | — | US | disclosed |
| US-11911464-B2 | Anti-parasitic immunological compositions | PROMMUNE, INC. (US) | 2024-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12552848-B2 | Hydrochloride salts of C5a receptor agonist peptides | C5AR1, C5AR2, C3AR1 | TFPI 1772/4885KDM1A 1521/4885GLP1R 635/4885 |
| US-20240238414-A1 | ANTI-PARASITIC IMMUNOLOGICAL COMPOSITIONS | C3AR1, C5AR1, C5AR2 | TFPI 895/4885KDM1A 2838/4885GLP1R 1960/4885 |
| US-11911464-B2 | Anti-parasitic immunological compositions | C3AR1, C5AR1, C5AR2 | TFPI 895/4885KDM1A 2838/4885GLP1R 1960/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.